UJAN Performance — Innovator U.S. Equity Ultra Buffer ETF - January
Data updated: 2026-09-28
UJAN returned +5.50% year to date and +11.22% over one year to Jul 2026. Annualised returns are +11.27% over 3 years and +8.02% over 5 years. The fund beat its Trading - Leveraged category average: $100 invested three years ago grew to $138, against $136 for the category, and to $111 over one year, against $105. Volatility over the past three years was 6.05% a year. In the 12 months to Jul 2026 the fund took in a net $35.3M, and assets reached $269.13M.
UJAN Growth of $100
What $100 invested in Innovator U.S. Equity Ultra Buffer ETF - January grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | UJAN | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $111 | $105 |
| 3 years (Aug 2023 – Jul 2026) | $138 | $136 |
| 5 years (Aug 2021 – Jul 2026) | $147 | $130 |
| Since data start (Feb 2020 – Jul 2026) | $164 | $143 |
UJAN Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.50% |
| 1 year | +11.22% |
| 3 years (annualised) | +11.27% |
| 5 years (annualised) | +8.02% |
UJAN Annual Returns
Calendar-year total returns of Innovator U.S. Equity Ultra Buffer ETF - January, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +5.50% |
| 2025 | +11.08% |
| 2024 | +13.17% |
| 2023 | +15.61% |
| 2022 | −5.74% |
| 2021 | +5.92% |
| 2020 (Feb–Dec) | +6.81% |
UJAN Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.8% | −0.2% | −2.2% | +4.7% | +1.8% | 0.0% | +0.7% | — | — | — | — | — |
| 2025 | +1.5% | −0.5% | −3.0% | −0.1% | +3.3% | +2.8% | +1.5% | +1.2% | +1.5% | +0.9% | +0.8% | +0.9% |
| 2024 | +1.0% | +2.5% | +1.3% | −1.4% | +2.9% | +1.5% | +0.6% | +1.3% | +0.6% | +0.3% | +1.5% | +0.4% |
| 2023 | +3.5% | −1.2% | +2.1% | +1.5% | +0.7% | +3.1% | +1.2% | +0.1% | −1.7% | −1.2% | +6.0% | +0.8% |
| 2022 | −2.0% | −1.3% | +1.1% | −3.8% | +0.2% | −2.2% | +2.2% | −0.9% | −1.0% | +1.3% | +0.4% | +0.3% |
| 2021 | −1.0% | +1.0% | +2.0% | +1.0% | +0.3% | +0.4% | +0.3% | +0.5% | −0.2% | +0.8% | +0.2% | +0.4% |
| 2020 | — | −3.3% | −5.0% | +5.0% | +1.9% | +1.2% | +1.9% | +2.0% | −1.2% | −0.5% | +4.3% | +0.8% |
UJAN Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 6.05%
- 3-year Sharpe ratio: 1.12 (vs 4.5% risk-free rate)
- Best month: +5.98% (Nov 2023)
- Worst month: −3.02% (Mar 2025)
UJAN Fund Flows
Monthly money in and out of Innovator U.S. Equity Ultra Buffer ETF - January, from SEC Form N-PORT.
- 12-month net flow: $35.3M
- 12-month gross sales (incl. reinvestments): $113.5M
- Sales ÷ redemptions: 1.45×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $0 | $46.5M | −$46.5M |
| Jun 2026 | $0 | $6.8M | −$6.8M |
| May 2026 | $0 | $9.1M | −$9.1M |
| Apr 2026 | $2.2M | $0 | $2.2M |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $7.6M | $0 | $7.6M |
| Jan 2026 | $101.6M | $1.1M | $100.5M |
| Dec 2025 | $1.1M | $3.2M | −$2.1M |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $0 | $3.2M | −$3.2M |
| Sep 2025 | $0 | $2.1M | −$2.1M |
| Aug 2025 | $1.0M | $6.2M | −$5.2M |
UJAN Assets Under Management
Net assets of Innovator U.S. Equity Ultra Buffer ETF - January by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $269.13M |
| 2026-04-30 | $323.77M |
| 2026-01-31 | $307.17M |
| 2025-10-31 | $202.89M |
| 2025-07-31 | $206.09M |
| 2025-04-30 | $247.63M |
| 2025-01-31 | $185.63M |
| 2024-10-31 | $160.43M |
| 2024-07-31 | $169.95M |
| 2024-04-30 | $192.86M |
| 2024-01-31 | $179.76M |
| 2023-10-31 | $115.86M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.